跳至主要内容
临床试验/JPRN-UMIN000034453
JPRN-UMIN000034453已完成未知

Clinical implications of postoperative carbohydrate antigen 19-9 as a serological indicator of positive resection margin and occult distant metastasis in patients with resected pancreatic cancer - Clinical implications of postoperative carbohydrate antigen 19-9 in patients with resected pancreatic cancer

Tochigi Cancer Center0 个研究点目标入组 166 人开始时间: 2018年10月11日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
166

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with macroscopically positive resection margin or distant metastasis were excluded. Patients with Pre-CA 19-9 < 5 U/ml were excluded. CA 19-9 values were not included in the analysis if serum total bilirubin was >2.0 mg/dl at the time of assay.

研究者

相似试验